AARD vs EIX · $284.4M cap vs P/E 7.3, rev $17.60B
Aardvark Therapeutics, Inc. Common Stock (AARD) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
AARD does not have a complete income-statement cache yet.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
AARD currently screens at market cap $284.4M. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the AARD and EIX stock pages for the full models.
Not investment advice.